Tracked deals
5
5 tracked deals across 2022-2025.
Operating Company
Healthcare
Vivo Infusion
Denver, Colorado, United States
Leading provider of accessible, affordable, and safe community-based infusion and injection care, operating state-of-the-art outpatient infusion facilities and providing home infusion/injection care for patients with compromised immune systems, infectious diseases, and other medical conditions.
- Focus Areas
- Ambulatory infusion centers, Outpatient infusion services, Home infusion services
- Website
- vivoinfusion.com
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Addon
3 addon · 2 buyout
Vivo Infusion Acquisition Volume by Year
Last 4 years
Supporting Data
Recent Transactions
-
- Buyer
- Vivo Infusion, InTandem Capital Partners
- Target
- Neurology Institute of San Antonio (NISA), Vista Infusions
- Seller
- Dr. Suzanne Gazda, Dr. Braden Neiman
- Industry
- Healthcare Services
- Location
- Texas, United States
- Type
- Addon
Vivo Infusion has acquired the Neurology Institute of San Antonio (NISA) and Vista Infusions, expanding its ambulatory infusion and neurology services footprint in Texas. The deal brings Vivo to nearly 90 infusion centers across 15 states and increases its presence in Texas to about 20 locations; financial terms were not disclosed.
-
- Buyer
- Vivo Infusion, InTandem Capital Partners
- Target
- Infusion Associates
- Seller
- Boyne Capital
- Industry
- Healthcare Services
- Location
- Michigan, United States
- Type
- Addon
Vivo Infusion, a national provider of community-based ambulatory infusion and injection services, has acquired Infusion Associates, a Midwest-focused ambulatory infusion operator headquartered in Grand Rapids, Michigan. The deal—sold by Boyne Capital and supported by Vivo's investor InTandem Capital Partners—adds Infusion Associates' 14 locations in Michigan, Minnesota, Ohio and Wisconsin to the Vivo platform as it nears management of ~80 centers across 15 states; financial terms were not disclosed.
-
June 20, 2023
- Buyer
- Vivo Infusion
- Target
- Specialty Infusion
- Industry
- Healthcare Services
- Location
- United States
- Type
- Buyout
Vivo Infusion, a national provider of community-based ambulatory infusion and injection care, has acquired Specialty Infusion, a provider of ambulatory infusion and specialty pharmacy services operating 14 centers across New York, Massachusetts, and New Jersey. The deal expands Vivo's footprint to a combined 55 ambulatory infusion centers across ten states; financial terms were not disclosed.
-
January 31, 2023
- Buyer
- Vivo Infusion
- Target
- CIVIC Infusion
- Industry
- Healthcare Services
- Location
- Connecticut, United States
- Type
- Buyout
Vivo Infusion, a provider of community-based ambulatory infusion services, has acquired CIVIC Infusion, which operates infusion centers in Connecticut and New York. CIVIC co-founders Drs. Barry Stein and Robert Roteman will join Vivo as Medical Directors; the combined organization now reaches 36 ambulatory infusion centers across nine states. Financial terms were not disclosed.
-
September 15, 2022
- Buyer
- Vivo Infusion, InTandem Capital Partners
- Target
- Infusion Center of Pennsylvania
- Seller
- Dr. Robert Singh, Dr. Emma Singh
- Industry
- Healthcare Services
- Location
- Pennsylvania, United States
- Type
- Addon
Vivo Infusion, a portfolio company of InTandem Capital Partners, has acquired Infusion Center of Pennsylvania (ICPA), the largest non-hospital infusion provider in the greater Philadelphia region. The add-on expands Vivo's footprint into Pennsylvania and New Jersey and adds home infusion and specialty pharmacy capabilities to its ambulatory infusion platform.
Related Acquisition Pages
Healthcare Services Buyers & Acquisitions
5 tracked deals by Vivo Infusion.
Acquisitions in Connecticut
1 tracked deal by Vivo Infusion.
Acquisitions in Michigan
1 tracked deal by Vivo Infusion.
Acquisitions in Pennsylvania
1 tracked deal by Vivo Infusion.
Acquisitions in Texas
1 tracked deal by Vivo Infusion.
Selling a company? Get in front of buyers like Vivo Infusion
Turn tracked acquisition activity into an outreach-ready buyer list.